If you are leasing a car, what’s the point of paying thousands of dollars due at lease signing? My contract says tax, title, fees and licensing — but then wouldn’t I have to pay that again at the end ...
Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
Another day, another AI mega raise. Ricursive Intelligence, a frontier AI lab, announced on Monday that it has raised $300 million in a Series A round of funding at a $4 billion valuation. Notably, ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
Three Democrats on the House Financial Services Committee have published an open letter to Securities and Exchange Commission (SEC) Chairman Paul Atkins regarding the lack of crypto enforcement ...
If you’re reading this article, there’s a good chance it’s because you came across a confusing new term like Shonen or Isekai in an article about anime and then clicked on a link hoping to learn more.
Minecraft is entering a new era in 2026. With the launch of Minecraft Java 26.1, Mojang is not just releasing another content patch — it’s introducing a new yearly versioning system and laying down ...
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results